InvestorsHub Logo
Followers 197
Posts 24670
Boards Moderated 0
Alias Born 04/03/2010

Re: ae kusterer post# 692685

Monday, 05/20/2024 9:21:19 AM

Monday, May 20, 2024 9:21:19 AM

Post# of 700285
Poly-ICLC is a different company's DRUG. Not part of any natural dendritic cell maturation process. It works by pretending to be a VIRUS and stimulating other processes in the body when DCVax-L is injected. The entire notion is incorrect, and as I said, it is not in that particular patent that was referenced in the post to which I just previously referred. It's not included in any version of DCVax, either Direct or DCVax-L It's another company's carefully created, manufactured, drug and NWBO did not have a patent to make it any more than they had a patent to make Keytruda. They also have never claimed they make it nor that they sourced it from Uncover for their manufacturing.

I too, hope they coordinate and present trials with the combination in the future. The results are wonderful. But sometimes people make things up because they want to believe something. They get it in their head. Poly-ICLC is an adjuvant treatment in all of the trials. It is injected separately in an intramuscular injection. The UCLA formula for ATL-DC and DCVax-L are the same. There is no disconnection, as has been claimed by some shorts and so there is no need to further promote this false theory that will only create confusion as there is simply no basis to it.

I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News